(Q28240536)

Patterned loss of hair in man; types and incidence

PubMed

volume

15

0 references

issue

3

0 references

page(s)

217-30

0 references

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Prevalence of male and female pattern hair loss in Maryborough.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Quality of life assessment in male patients with androgenetic alopecia: result of a prospective, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

The Development of Clinical Practice Guidelines and Guidance Statements of the American College of Physicians: Summary of Methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Efficacy and safety of finasteride therapy for androgenetic alopecia: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Persistent sexual side effects of finasteride for male pattern hair loss.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Adverse side effects of 5α-reductase inhibitors therapy: persistent diminished libido and erectile dysfunction and depression in a subset of patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Depressive symptoms and suicidal thoughts among former users of finasteride with persistent sexual side effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

THERAPEUTIC HOTLINE: Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Male breast cancer and 5α-reductase inhibitors finasteride and dutasteride

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Hair: what is new in diagnosis and management? Female pattern hair loss update: diagnosis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Lack of efficacy of finasteride in postmenopausal women with androgenetic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Measuring reversal of hair miniaturization in androgenetic alopecia by follicular counts in horizontal sections of serial scalp biopsies: results of finasteride 1 mg treatment of men and postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Finasteride treatment of female pattern hair loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Hair loss in women with hyperandrogenism: four cases responding to finasteride

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Effects of in utero exposure to finasteride on androgen-dependent reproductive development in the male rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with male pattern hair loss: a randomized, double-blind, placebo-controlled, phase III study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

The efficacy and safety of 5α-reductase inhibitors in androgenetic alopecia: a network meta-analysis and benefit-risk assessment of finasteride and dutasteride

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Comparing the therapeutic effects of finasteride gel and tablet in treatment of the androgenetic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Evidence-based treatments for female pattern hair loss: a summary of a Cochrane systematic review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Treatment of female pattern hair loss with oral antiandrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Prospective cohort study on the effects and tolerability of flutamide in patients with female pattern hair loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Treatment of hyperandrogenic alopecia in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Treatment of female pattern hair loss with the androgen receptor antagonist flutamide

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Hair regrowth in a male patient with extensive androgenetic alopecia on estrogen therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Comparison of the efficacy and safety of topical minoxidil and topical alfatradiol in the treatment of androgenetic alopecia in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Topical estrogen accelerates hair regrowth in mice after chemotherapy-induced alopecia by favoring the dystrophic catagen response pathway to damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Minoxidil use in dermatology, side effects and recent patents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

New investigational drugs for androgenetic alopecia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Comparative efficacy of various treatment regimens for androgenetic alopecia in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

The effects of minoxidil, 1% pyrithione zinc and a combination of both on hair density: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Effects of minoxidil 2% vs. cyproterone acetate treatment on female androgenetic alopecia: a controlled, 12-month randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

A multicenter, randomized, placebo-controlled, double-blind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Pattern hair loss in men: diagnosis and medical treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

A randomized double-blind placebo-controlled pilot study to assess the efficacy of a 24-week topical treatment by latanoprost 0.1% on hair growth and pigmentation in healthy volunteers with androgenetic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Ketocazole as an adjunct to finasteride in the treatment of androgenetic alopecia in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Reversal of androgenetic alopecia by topical ketoconzole: Relevance of anti-androgenic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Melatonin maintains mitochondrial membrane potential and attenuates activation of initiator (casp-9) and effector caspases (casp-3/casp-7) and PARP in UVR-exposed HaCaT keratinocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Melatonin increases anagen hair rate in women with androgenetic alopecia or diffuse alopecia: results of a pilot randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Topical melatonin for treatment of androgenetic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

The latest innovations in hair transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Promotional effect of platelet-rich plasma on hair follicle reconstitution in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

The role of platelet plasma growth factors in male pattern baldness surgery.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Letter: Platelet-rich plasma for treating male pattern baldness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Enhanced Effect of Platelet-Rich Plasma Containing a New Carrier on Hair Growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Adenosine increases anagen hair growth and thick hairs in Japanese women with female pattern hair loss: a pilot, double-blind, randomized, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Hair growth and rejuvenation: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Clinical efficacy of a cosmetic treatment by Crescina(®) human follicle stem cell on healthy males with androgenetic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Effect of topical application of raspberry ketone on dermal production of insulin-like growth factor-I in mice and on hair growth and skin elasticity in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

The hair growth promoting effect of Sophora flavescens extract and its molecular regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Curcuma aeruginosa, a novel botanically derived 5α-reductase inhibitor in the treatment of male-pattern baldness: a multicenter, randomized, double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Effect of Cuscuta reflexa Roxb on androgen-induced alopecia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Human hair growth enhancement in vitro by green tea epigallocatechin-3-gallate (EGCG).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Ketoconazole shampoo: effect of long-term use in androgenic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

A randomized, double-blind, placebo-controlled trial to determine the effectiveness of botanically derived inhibitors of 5-alpha-reductase in the treatment of androgenetic alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

A pilot study evaluating the efficacy of topically applied niacin derivatives for treatment of female pattern alopecia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Autologous platelet-rich plasma: a potential therapeutic tool for promoting hair growth.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Historical review of melanoma treatment and outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Utilizing electromagnetic radiation for hair growth: a critical review of phototrichogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

The use of low-level light therapy in the treatment of androgenetic alopecia and female pattern hair loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

HairMax LaserComb laser phototherapy device in the treatment of male androgenetic alopecia: A randomized, double-blind, sham device-controlled, multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Efficacy and safety of a low-level laser device in the treatment of male and female pattern hair loss: a multicenter, randomized, sham device-controlled, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

The current role of laser/light sources in the treatment of male and female pattern hair loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Persistent Sexual Side Effects of Finasteride: Could They Be Permanent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5

Effect ofCitrullus colocynthisSchrad fruits on testosterone-induced alopecia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS40257-014-0077-5